Opioid maker Mallinckrodt reaches $1.6 billion settlement

Generic drug company Mallinckrodt has reached a tentative agreement to pay $1.6 billion to settle lawsuits over its role in the opioid crisis, it announced Tuesday.

Hundreds of lawsuits accuse Mallinckrodt of helping to create and amplify the opioid crisis, but the company is hoping to make a lot...